Synergistic Treatment System for Hematopoietic Stem Cell Transplant Recipients

A comprehensive treatment system integrating machine learning, blockchain, IoT, and new materials to optimize prophylaxis and treatment of invasive Aspergillus and Candida infections in high-risk patients.

The original patent addressed the treatment of various cancers and hematopoietic stem cell transplant recipients with graft-versus-host disease using posaconazole. However, it lacked a holistic approach to patient care, relying solely on the administration of the anti-fungal medication. The new inventive concept tackles this limitation by introducing a synergistic system that combines AI-powered risk prediction, blockchain-based tracking, IoT-enabled real-time monitoring, and targeted delivery of posaconazole using novel composite materials.

The system comprises four main components: (1) a machine learning module that predicts the risk of invasive Aspergillus and Candida infections in patients based on their medical history and current health status; (2) a treatment module that administers posaconazole to high-risk patients; (3) a blockchain-based tracking module that monitors treatment adherence and ensures secure data sharing between healthcare providers and researchers; and (4) an IoT-enabled wearable device that tracks white blood cell counts and alerts healthcare providers of potential infection risk. Additionally, a novel composite material is used for targeted delivery of posaconazole, comprising a nanoparticle carrier system and a bioresponsive polymer coating that releases the nanoparticle carrier system in response to changes in pH or temperature.

The new claims introduce a synergistic system that combines distinct technologies to create a more powerful and effective treatment approach. The integration of AI, blockchain, IoT, and new materials provides a non-obvious solution to the problem of invasive Aspergillus and Candida infections in high-risk patients.

Alternative embodiments may include the use of different AI algorithms, blockchain platforms, or IoT devices. Variations may also include the integration of additional technologies, such as natural language processing or computer vision, to further enhance the system's capabilities.

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of cancer treatment, hematopoietic stem cell transplantation, and infectious disease management. The system's ability to optimize treatment outcomes, reduce healthcare costs, and improve patient safety makes it an attractive solution for healthcare providers, pharmaceutical companies, and medical device manufacturers.